EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Gilteritinib response in acute myeloid leukemia harboring a rare FLT3 juxtamembrane domain mutation with subsequent clonal evolution

Fumihiko Nakao, Takahiro Shima, Ken Takigawa, Yuichiro Semba, Fumiaki Jinnouchi, Takuji Yamauchi, Jun Odawara, Yoshikane Kikushige, Yasuo Mori, Koji Kato, Takahiro Maeda, Koichi Akashi

Annals of Hematology · 09.05.2026 · 105 (7)

DOI: 10.1007/s00277-026-07061-6 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, online erschienen am 09.05.2026. Verfasst von Fumihiko Nakao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan. Hauptthemen laut MEDLINE: fms-Like Tyrosine Kinase 3, Aniline Compounds, Pyrazines, Leukemia, Myeloid, Acute. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: a Grant-in-Aid for Early-Career Scientists from the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science, he Shin-nihon Foundation of Advanced Medical Treatment Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

fms-Like Tyrosine Kinase 3Aniline CompoundsPyrazinesLeukemia, Myeloid, AcuteClonal EvolutionMutation, MissenseHumansFemaleAdultHematopoietic Stem Cell TransplantationProtein DomainsMutation

Stichwörter der Autor:innen

FLT3 V579AAcute myeloid leukemiaGilteritinib

Substanzen

fms-Like Tyrosine Kinase 3gilteritinibAniline CompoundsFLT3 protein, humanPyrazines

Autor:innen und Institutionen

  • Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Department of Hematology, Kyushu Medical Center, Fukuoka, Japan.
  • Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan. shima@fukuoka-u.ac.jp.
  • Division of Precision Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

Förderung

  • a Grant-in-Aid for Early-Career Scientists from the Japan Society for the Promotion of Science
  • a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science
  • he Shin-nihon Foundation of Advanced Medical Treatment Research
  • he Kaibara Morikazu Medical Science Promotion Foundation

Zitieren

APA

Nakao, F., Shima, T., Takigawa, K., Semba, Y., Jinnouchi, F., Yamauchi, T., Odawara, J., Kikushige, Y., Mori, Y., Kato, K., Maeda, T., & Akashi, K. (2026). Gilteritinib response in acute myeloid leukemia harboring a rare FLT3 juxtamembrane domain mutation with subsequent clonal evolution. Annals of Hematology, 105(7). https://doi.org/10.1007/s00277-026-07061-6

Vancouver

Nakao F, Shima T, Takigawa K, Semba Y, Jinnouchi F, Yamauchi T, et al. Gilteritinib response in acute myeloid leukemia harboring a rare FLT3 juxtamembrane domain mutation with subsequent clonal evolution. Annals of Hematology. 2026;105(7). doi:10.1007/s00277-026-07061-6

BibTeX
@article{Nakao2026,
  author = {Nakao, Fumihiko and Shima, Takahiro and Takigawa, Ken and Semba, Yuichiro and Jinnouchi, Fumiaki and Yamauchi, Takuji and Odawara, Jun and Kikushige, Yoshikane and Mori, Yasuo and Kato, Koji and Maeda, Takahiro and Akashi, Koichi},
  title = {Gilteritinib response in acute myeloid leukemia harboring a rare FLT3 juxtamembrane domain mutation with subsequent clonal evolution},
  journal = {Annals of Hematology},
  year = {2026},
  volume = {105},
  number = {7},
  doi = {10.1007/s00277-026-07061-6}
}
Kostenlos starten →